What is The Jackson Laboratory?
Operating at the intersection of basic research and clinical application, The Jackson Laboratory is a global leader in the development of mouse models, stem cell systems, and sophisticated data-driven analytical tools. By providing the scientific community with standardized, high-quality research models, the institution facilitates critical studies into cancer, aging, and neurological disorders. Its market position is defined by its unique ability to bridge the gap between fundamental genetic discovery and the development of therapeutic interventions, serving as an essential partner for academic, pharmaceutical, and biotechnology researchers worldwide.
How much funding has The Jackson Laboratory raised?
The Jackson Laboratory has raised a total of $87M across 4 funding rounds:
Unspecified
$58M
Unspecified
$6M
Unspecified
$10.5M
Unspecified
$12.5M
Unspecified (2011): $58M with participation from National Institutes of Health
Unspecified (2017): $6M led by National Institute of General Medical Sciences
Unspecified (2017): $10.5M supported by National Institutes of Health
Unspecified (2018): $12.5M featuring Maine Technology Institute
Key Investors in The Jackson Laboratory
National Institutes of Health
The National Institutes of Health is the primary agency of the United States government responsible for biomedical and health-related research, providing critical federal support for scientific advancement.
Maine Technology Institute
Maine Technology Institute provides grants and equity investments aimed at fostering innovation and supporting the growth of the entrepreneurial ecosystem within the state of Maine.
National Institute of General Medical Sciences
The National Institute of General Medical Sciences supports fundamental research to enhance the understanding of biological processes, which is essential for advancements in disease diagnosis and prevention.
What's next for The Jackson Laboratory?
Looking ahead, the infusion of capital will likely be directed toward expanding the laboratory's high-throughput genomic sequencing capabilities and enhancing its computational biology infrastructure. As the demand for personalized medicine grows, The Jackson Laboratory is positioned to scale its production of specialized disease models, thereby shortening the development cycle for novel therapeutics. By maintaining its focus on open-science initiatives and collaborative research, the institution is set to remain a cornerstone of the biomedical ecosystem, driving long-term value through scientific excellence and technological innovation.
See full The Jackson Laboratory company page
